Your session is about to expire
← Back to Search
Xenograft
Fish Skin Grafts + PRP for Chronic Wounds
N/A
Waitlist Available
Research Sponsored by St Elizabeth Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient is over the age of 18 years
Target wound size must be between 2 cm x 2 cm x 0.1 cm deep and 10 cm x 10 cm x 5 cm deep
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial looks at using special grafts with healing proteins to help chronic wounds heal faster than with just a graft.
Who is the study for?
This trial is for adults over 18 with chronic, nonhealing wounds sized between roughly 0.8x0.8 inches to about 4x4 inches deep, who are patients of specific doctors and can undergo standard Kerecis® xenograft surgery. It's not for those allergic to fish material, undergoing chemo or radiation therapy, have autoimmune wound origins, don't speak English, or have very low hemoglobin levels.Check my eligibility
What is being tested?
The study is testing the effectiveness of using a fish skin graft (Kerecis® xenograft) with Platelet Rich Plasma (PRP) versus the graft alone on chronic wounds that haven't healed after six weeks of treatment. Participants will be randomly assigned to one of these two approaches.See study design
What are the potential side effects?
Potential side effects may include reactions at the wound site due to sensitivity to fish skin materials in the grafts or complications from PRP therapy such as pain and infection at injection sites.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18 years old.
Select...
My wound size fits within the specified dimensions.
Select...
I am eligible for surgery using Kerecis® graft.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to wound being deemed healed or 6 months
Secondary outcome measures
Wound quality of life
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Xenograft and PRPExperimental Treatment1 Intervention
The Kerecis® xenograft (Kerecis® Omega3 MariGen) will be applied with the application of PRP.
Group II: Xenograft onlyActive Control1 Intervention
The Kerecis® xenograft (Kerecis® Omega3 MariGen) will be applied without the application of PRP.
Find a Location
Who is running the clinical trial?
St Elizabeth HealthcareLead Sponsor
5 Previous Clinical Trials
14,202 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not speak English.My hemoglobin level was below 6.9 g/dL at least a month before my planned surgery.My wound is caused by an autoimmune disease.I am currently receiving chemotherapy or radiation therapy.I am over 18 years old.My wound has not healed after 6 weeks of treatment.You are a patient of Dr. Eldridge, Dr. Glenn, or Dr. Worley.My wound size fits within the specified dimensions.I am eligible for surgery using Kerecis® graft.
Research Study Groups:
This trial has the following groups:- Group 1: Xenograft and PRP
- Group 2: Xenograft only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts underway for this research endeavor?
"As per the data available on clinicaltrials.gov, this study is no longer seeking participants; it was initially posted on March 1st 2023 and last edited two days later. Although there are no openings for patients in this trial presently, 14 other studies are actively recruiting at present."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger